IPP Bureau
.png "in-cosmetics Asia 2025 smashes records, draws global beauty elite")
in-cosmetics Asia 2025 smashes records, draws global beauty elite
By IPP Bureau - November 21, 2025
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
Thyrocare launches comprehensive GLP-1 health check across India
By IPP Bureau - November 21, 2025
Glucagon-Like Peptide-1 is a natural hormone that regulates blood sugar, controls appetite, and slows digestion
FDA nod to Koselugo for adults with Rare NF1 tumors, expanding life-changing treatment
By IPP Bureau - November 21, 2025
Teva launches 'Teva Rise' to harness global innovation and transform healthcare
By IPP Bureau - November 21, 2025
The initiative aims to connect startups and tech companies with its business units,
Lilly expands biotech footprint with new Gateway Labs in Philadelphia
By IPP Bureau - November 21, 2025
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
Sudeep Pharma eyes Rs. 895 crore fundraising from debut on bourses
By IPP Bureau - November 19, 2025
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
Cardiol Therapeutics wins US patent protection for heart-disease drug platform
By IPP Bureau - November 19, 2025
The patent will lock in broad protection for the company’s lead therapy CardiolRx and its novel subcutaneous candidate CRD-38
Meduloc wins FDA green light for new class of bone-fracture fixation system
By IPP Bureau - November 19, 2025
The cleared system pairs a flexible nitinol implant with a deployable prong-locking mechanism, delivering rotational and length stability
Roche’s Giredestrant sets new benchmark in early breast cancer treatment
By IPP Bureau - November 19, 2025
The study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in invasive disease-free survival
.png "Time Medical launches India’s first low-field TOF MRI for nationwide aneurysm screening")
Time Medical launches India’s first low-field TOF MRI for nationwide aneurysm screening
By IPP Bureau - November 19, 2025
India presents one of the world’s largest untapped opportunities for neurovascular screening
HRV Pharma and MetroChem forge CDMO alliance to fast-track NCE-1 API development
By IPP Bureau - November 19, 2025
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
Evonik and InVitria form strategic partnership to supply animal-free albumin to global biopharma market
By IPP Bureau - November 18, 2025
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
Kingsway Pharma acquires minority stake in CIGA Healthcare to boost US diagnostic access
By IPP Bureau - November 18, 2025
This move positions the U.S.-based consumer healthcare company for a significantly larger role in the rapidly expanding at-home and retail diagnostic testing market
Galmed’s Aramchol shows promise in overcoming gastrointestinal cancer drug resistance
By IPP Bureau - November 18, 2025
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
